AngioDynamics Completes Acquisition of Microsulis Medical
ALBANY, N.Y., Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a
leading provider of innovative, minimally invasive medical devices for
vascular access, surgery, peripheral vascular disease and oncology, today said
it has completed the previously announced acquisition of certain assets of
Microsulis Medical Ltd.
Microsulis developed the Acculis MTA microwave ablation system, which utilizes
a single, high-power, high-frequency 2.45 GHz saline-cooled applicator that
may provide advantages to clinicians and patients, including faster ablation
of soft tissue.
"We are excited to welcome the Microsulis team to AngioDynamics," said Joseph
M. DeVivo, President and CEO of AngioDynamics. "With the addition of
microwave, we have a complete offering of thermal and non-thermal
technologies, further building on our status as a market-leader in the $250
million global tissue ablation market."
AngioDynamics Inc. is a leading provider of innovative, minimally invasive
medical devices used by professional healthcare providers for vascular access,
surgery, peripheral vascular disease and oncology. AngioDynamics' diverse
product lines include market-leading ablation systems, fluid management
systems, vascular access products, angiographic products and accessories,
angioplasty products, drainage products, thrombolytic products and venous
products. More information is available at www.AngioDynamics.com.
AngioDynamics, the AngioDynamics logo and Acculis are trademarks and/or
registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:
Mark Frost, CFO
(800) 772-6446 x1981
Investor Relations Contacts:
EVC Group, Inc.
Greg Gin/Robert Jones
(646) 445-4801; (646) 201-5447
EVC Group, Inc.
Press spacebar to pause and continue. Press esc to stop.